Molecular Neuroimaging, LLC

New Haven, Connecticut 06511

0 studies enrolling now · 19 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Alzheimer's Disease (AD), Alzheimers Disease, Amyotrophic Lateral Sclerosis, Chronic Traumatic Encephalopathy (CTE), Cortical Basal Syndrome (CBS), Frontal Temporal Dementia (FTD), Healthy Volunteers, Parkinson Disease, Parkinson's Disease, Parkinson's Disease (PD)

Studies at this site

• Evaluation of Microglial Activation in ALS With [18F]PBR06 (Peripheral Benzodiazepine Receptor-06) PET — Completed
• Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain — Completed
• Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects — Completed
• Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT — Stopped early
• Assessment of the Biodistribution and Safety of [18F]MNI-968 in Healthy Subjects — Completed
• Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects — Completed
• Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain — Completed
• A Study to Evaluate Safinamide's Effect on Dopamine and Serotonin's Availability by Using Brain Imaging — Stopped early
• Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease — Completed
• Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies — Completed
• Efficacy and Safety of MNI-672 SPECT for Detection/Exclusion of Cerebral B-amyloid in AD Subjects Compared to HVs. — Completed
• Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects — Completed
• Efficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's Disease — Status unconfirmed
• Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a — Completed
• Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations — Completed
• Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy — Completed
• Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects — Stopped early
• Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects — Stopped early
• Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects — Completed